Erik Ian Tucker
Principal investigator.
Biotech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2015First federal award
$19.9MFederal grants as PI21 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
21 awards · $19.9M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| May 9, 2023 | NIH | SBIR Phase II Antithrombotic Protein C Activator for Hemodialysis | $999K | ARONORA INC |
| May 20, 2022 | NIH | SBIR Phase II Factor XII Inhibitor for Surface Initiated Thrombosis | $953K | ARONORA INC |
| Apr 30, 2022 | NIH | SBIR Phase II Antithrombotic Protein C Activator for Hemodialysis | $999K | ARONORA INC |
| May 19, 2021 | NIH | SBIR Phase II Factor XII Inhibitor for Surface Initiated Thrombosis | $982K | ARONORA INC |
| Mar 26, 2021 | NIH | SBIR Phase II Antithrombotic Protein C Activator for Hemodialysis | $998K | ARONORA INC |
| May 22, 2020 | NIH | SBIR Phase II Factor XII Inhibitor for Surface Initiated Thrombosis | $1000K | ARONORA INC |
| May 6, 2020 | NIH | SBIR Phase II Antithrombotic Protein C Activator for Hemodialysis | $1.5M | ARONORA INC |
| Jul 22, 2019 | NIH | SBIR Phase II Factor XI inhibitor for thrombosis | $1000K | ARONORA INC |
| May 13, 2019 | NIH | SBIR Phase II Antithrombotic Protein C Activator for Hemodialysis | $994K | ARONORA INC |
| Mar 15, 2019 | NIH | SBIR Phase II Therapeutic Protein C Activator for Myocardial Ischemia | $999K | ARONORA INC |
| Jul 5, 2018 | NIH | SBIR Phase II Factor XI inhibitor for thrombosis | $1000K | ARONORA INC |
| Jun 18, 2018 | NIH | SBIR Phase II HLS- Factor XII Inhibitor for Surface Initiated Thrombosis | $963K | ARONORA INC |
| Mar 29, 2018 | NIH | SBIR Phase II Therapeutic Protein C Activator for Myocardial Ischemia | $999K | ARONORA INC |
| Sep 13, 2017 | NIH | SBIR Phase II Therapeutic factor XI blockade for sepsis | $360K | ARONORA INC |
| Jul 20, 2017 | NIH | SBIR Phase II HLS- Factor XII Inhibitor for Surface Initiated Thrombosis | $999K | ARONORA INC |
| May 8, 2017 | NIH | SBIR Phase II Therapeutic Protein C Activator for Myocardial Ischemia | $998K | ARONORA INC |
| Jul 31, 2016 | NIH | SBIR Phase II HLS- Factor XII Inhibitor for Surface Initiated Thrombosis | $300K | ARONORA INC |
| Jun 16, 2016 | NIH | SBIR Phase II Therapeutic Thrombin Analogs | $873K | ARONORA INC |
| Apr 9, 2016 | NIH | SBIR Phase II Therapeutic factor XI blockade for sepsis | $997K | ARONORA INC |
| Jun 30, 2015 | NIH | SBIR Phase II Therapeutic Thrombin Analogs | $958K | ARONORA INC |
| Mar 14, 2015 | NIH | SBIR Phase II Therapeutic factor XI blockade for sepsis | $999K | ARONORA INC |
Peer ranks
Federal funding#4
Awards as PI#14
Patents#273
Companies
- ARONORA INCLinked by awards · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.